Intracranial hemorrhage in children with immune thrombocytopenic purpura

被引:61
作者
Iyori, H
Bessho, F
Ookawa, H
Konishi, S
Shirahata, A
Miyazaki, S
Fujisawa, K
Akatsuka, J
机构
[1] Kanagawa Prefectural Atsugi Hosp, Div Pediat, Atsugi, Kanagawa 2438588, Japan
[2] Jikei Univ, Sch Med, Dept Pediat, Minato Ku, Tokyo 1058461, Japan
[3] Kyorin Univ, Sch Med, Dept Pediat, Tokyo, Japan
[4] Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan
[5] Nishinari Publ Hlth Ctr, Osaka, Japan
[6] Univ Occupat & Environm Hlth, Sch Med, Dept Pediat, Fukuoka, Japan
[7] Fac Med, Saga Med Sch, Dept Pediat, Saga, Japan
[8] Seitoku Univ, Chiba, Japan
关键词
immune thrombocytopenic purpura; intracranial hemorrhage;
D O I
10.1007/s002770000219
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We sent questionnaires to hospitals in Japan in order to study the incidence and conditions of intracranial hemorrhage (ICH) in children with immune thrombocytopenic purpura (ITP). From 1980 to 1995, 11 cases of ICH were reported in eight patients with ITP at 35 institutions. One patient had ICH four times, but only one patient died of the condition. From 1990 through 1995, ICH occurred in four (0.52%) of 772 patients with ITP. None of the patients died. The platelet count when ICH occurred was 5.2+/-3.7 x 10(9)/l (mean+/-SD) (n = 11). Four of the eight patients (1980-1995) had received active treatment [e.g. intravenous immunoglobulin G (i.v. IgG)I immediately before ICH occurred. In seven cases (1980-1995), possible causes of ICH, including menstruation (n = 2) and viral infections (n = 3), were identified. Systemic lupus erythematosus (SLE) later developed in three patients. Although the incidence of ICH in children with ITP has not decreased compared with the rates in earlier studies, the mortality rate has decreased markedly. Our results suggest that menstruation, infection, and risk factors for progression to SLE may help to predict ICH in children with ITP. Large-scale prospective trials are needed to identify risk factors for ICH.
引用
收藏
页码:691 / 695
页数:5
相关论文
共 6 条
[1]  
AKATSUKA J, 1985, LONG TERM FOLLOW UP, P384
[2]  
KURATA Y, 1994, THROMB HAEMOSTASIS, V71, P184
[3]   MORTALITY IN IMMUNE THROMBOCYTOPENIC PURPURA - REPORT OF 7 CASES AND CONSIDERATION OF PROGNOSTIC INDICATORS [J].
SCHATTNER, E ;
BUSSEL, J .
AMERICAN JOURNAL OF HEMATOLOGY, 1994, 46 (02) :120-126
[4]   LONG-TERM OBSERVATION OF 208 ADULTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA [J].
STASI, R ;
STIPA, E ;
MASI, M ;
CECCONI, M ;
SCIMO, MT ;
OLIVA, F ;
SCIARRA, A ;
PERROTTI, AP ;
ADOMO, G ;
AMADORI, S ;
PAPA, G .
AMERICAN JOURNAL OF MEDICINE, 1995, 98 (05) :436-442
[5]  
TSUBAKIO T, 1983, CLIN EXP IMMUNOL, V53, P697
[6]   Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura [J].
Zimmerman, SA ;
Ware, RE .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (04) :297-303